X-101398789-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_000169.3(GLA):c.797A>C(p.Asp266Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D266H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000169.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Fabry disease Pathogenic:1
Variant summary: GLA c.797A>C (p.Asp266Ala) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183472 control chromosomes (gnomAD). c.797A>C has been reported in the literature in individuals affected with Fabry Disease (Militaru_20). Additionally, no residual enzymatic activity detected in a male individual carrying the variant (Militaru_2019). These data indicate that the variant is very likely to be associated with disease. A different variant affecting the same codon has been classified as pathogenic by our lab (c.797A>T, p.Asp266Val), supporting the critical relevance of codon 266 to GLA protein function. The following publications have been ascertained in the context of this evaluation (PMID: 32042454, 31475953). ClinVar contains an entry for this variant (Variation ID: 228701). Based on the evidence outlined above, the variant was classified as pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Asp266Ala variant in GLA has been previously reported in 1 Chinese individual with Fabry disease (Tian 2013) and was absent from large population studies. In addition, 5 different variants at this position (p.Asp266Val, p.Asp266His, p.Asp266Asn; p.A sp266Glu and p.Asp266Tyr) have been reported in at least 5 individuals with Fabr y disease (Eng 1993, Ashton-Prolla 2000, Lee 2000, Germain 2002, Erdos 2008), ra ising the possibility that a change at this position may not be tolerated. Compu tational prediction tools and evolutionary conservation analysis also suggest th at this variant may impact the protein, though this information is not predictiv e enough to determine pathogenicity. In summary, while there is some suspicion f or a pathogenic role, the clinical significance of the p.Asp266Ala variant is un certain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at